OFFICES
- New York - P: (212) 351-3400
- San Francisco - P: (415) 573-1900
- Washington, D.C. - P: (202) 451-4900
Desmarais LLP Wins $57M Jury Verdict for Ravgen in Prenatal Genetic Testing Patent Trial
Following a weeklong trial, Desmarais LLP secured a $57 million jury verdict on behalf of the Maryland-based biotech firm Ravgen and its prenatal genetic testing technology against the Austin-based lab testing company Natera.
MOREFEATURED PARTNER
David J. Shaw
David is a trial lawyer who specializes in Section 337 investigations before the International Trade Commission, and has also represented clients in high-patent-volume U.S. District...
ALL